Aurora Cannabis Inc
TSX:ACB
Aurora Cannabis Inc
Cost of Revenue
Aurora Cannabis Inc
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Aurora Cannabis Inc
TSX:ACB
|
Cost of Revenue
-CA$261.8m
|
CAGR 3-Years
11%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
Bausch Health Companies Inc
TSX:BHC
|
Cost of Revenue
-$2.6B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-3%
|
|
Canopy Growth Corp
TSX:WEED
|
Cost of Revenue
-CA$336.8m
|
CAGR 3-Years
15%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
N/A
|
|
Sundial Growers Inc
NASDAQ:SNDL
|
Cost of Revenue
-CA$689.3m
|
CAGR 3-Years
-137%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Cronos Group Inc
TSX:CRON
|
Cost of Revenue
-$75.3m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-66%
|
CAGR 10-Years
N/A
|
|
C
|
Curaleaf Holdings Inc
CNSX:CURA
|
Cost of Revenue
-$1.3B
|
CAGR 3-Years
-55%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Aurora Cannabis Inc's Cost of Revenue?
Cost of Revenue
-261.8m
CAD
Based on the financial report for Dec 31, 2023, Aurora Cannabis Inc's Cost of Revenue amounts to -261.8m CAD.
What is Aurora Cannabis Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-23%
Over the last year, the Cost of Revenue growth was 21%. The average annual Cost of Revenue growth rates for Aurora Cannabis Inc have been 11% over the past three years , -23% over the past five years .